← k3vl4r
Log inGet started →

SYRE (Spyre Therapeutics Inc) Price Forecast

AI-generated price forecast for Spyre Therapeutics Inc (SYRE) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of September 2026: K3vl4r's AI model currently reads SYRE as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 90.68. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

90.68

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

SYRE forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~4 weeks out———
Daily~4 months out▼ Down-61.45%0%
Weekly~1.8 years out▼ Down-42.47%—

Latest SYRE news

From the market-news feed the forecasts are read against.

  • Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $36,000.00 in Stock · ldr:marketbeat.com · Sep 3
  • Spyre Therapeutics (SYRE) Down 16.6% Since Last Earnings Report: Can It Rebound? · Zacks · Sep 3
  • Spyre (SYRE) Fell 13% on Its Weakest Program. Its Best One Just Worked · Insider Monkey · Aug 31
  • Spyre Therapeutics: Catalyst-Rich Period But Easiest Money May Have Been Made (Downgrade) · SeekingAlpha · Aug 27
  • SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis · Zacks · Aug 26

🔒

See the full SYRE forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

SYRE forecast — frequently asked

Will SYRE go up?

K3vl4r's AI model currently reads SYRE as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the SYRE price prediction for 2026?

K3vl4r's model projects SYRE toward $86.25 over the next ~4 months, a -0.6% move from $86.79. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could SYRE reach?

Over its longest horizon (~~1.8 years), the model's projected target for SYRE is $86.88 (-0.4% vs $87.25). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

IMRXKPTIRGENASNDMISTIFRXCMPXHUMAKTTAACHACRVARDXBGMSTVRD

Will SYRE reach…?

Will SYRE reach $100.00?Will SYRE reach $200.00?Will SYRE reach $250.00?Will SYRE reach $500.00?

Or see the full SYRE price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare SYRE

SYRE vs IMRXSYRE vs KPTISYRE vs RGENSYRE vs ASNDSYRE vs MISTSYRE vs IFRX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.